AstraZeneca PLC Sees More Deals to Fill Out Pipeline

Reuters -- Anglo-Swedish drugmaker AstraZeneca is aggressively meeting potential acquisition partners as it prepares for generic competition from some of its best-selling drugs.

MORE ON THIS TOPIC